FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100063214> ?p ?o ?g. }

• W2100063214 endingPage "259" @default.
• W2100063214 startingPage "255" @default.
• W2100063214 abstract "Objective The purpose of this study was to determine if maternal serum concentrations of placenta growth factor (PlGF) and soluble Fms-like tyrosine kinase 1 receptor (s-Flt1) are more abnormal in patients with severe preeclampsia compared with mild preeclampsia. Study design Serum samples were collected from 32 control patients and 80 patients with mild or severe preeclampsia. PlGF and s-Flt1 concentrations were quantitated by enzyme-linked immunosorbent assay (ELISA). Results are expressed as median (Q1-Q3) unless stated otherwise. After normalization, serum markers were compared using one-way analysis of covariance (ANCOVA). Results Patients with preeclampsia had decreased levels of PlGF (75.1 ± 14 vs 391 ± 54 pg/mL, P < .0001) and elevated s-Flt1 concentration (1081 ± 108 vs 100.1 ± 26.9 pg/mL, P < .0001) compared with the respective controls (mean ± SEM). PlGF concentration was lower in patients with mild preeclampsia compared with severe, respectively (67 pg/mL [39-158] vs 24 pg/mL [4-57], P < .02). s-Flt1 was not different between mild and severe preeclampsia (674 pg/mL [211-1297] vs 1015 pg/mL [731-1948], P = .08). Conclusion PlGF and s-Flt1 serum levels are abnormal in patients with preeclampsia compared with controls, but only PlGF is more abnormal in severe preeclampsia compared with mild preeclampsia. The purpose of this study was to determine if maternal serum concentrations of placenta growth factor (PlGF) and soluble Fms-like tyrosine kinase 1 receptor (s-Flt1) are more abnormal in patients with severe preeclampsia compared with mild preeclampsia. Serum samples were collected from 32 control patients and 80 patients with mild or severe preeclampsia. PlGF and s-Flt1 concentrations were quantitated by enzyme-linked immunosorbent assay (ELISA). Results are expressed as median (Q1-Q3) unless stated otherwise. After normalization, serum markers were compared using one-way analysis of covariance (ANCOVA). Patients with preeclampsia had decreased levels of PlGF (75.1 ± 14 vs 391 ± 54 pg/mL, P < .0001) and elevated s-Flt1 concentration (1081 ± 108 vs 100.1 ± 26.9 pg/mL, P < .0001) compared with the respective controls (mean ± SEM). PlGF concentration was lower in patients with mild preeclampsia compared with severe, respectively (67 pg/mL [39-158] vs 24 pg/mL [4-57], P < .02). s-Flt1 was not different between mild and severe preeclampsia (674 pg/mL [211-1297] vs 1015 pg/mL [731-1948], P = .08). PlGF and s-Flt1 serum levels are abnormal in patients with preeclampsia compared with controls, but only PlGF is more abnormal in severe preeclampsia compared with mild preeclampsia." @default.
• W2100063214 created "2016-06-24" @default.
• W2100063214 creator A5017513634 @default.
• W2100063214 creator A5046597133 @default.
• W2100063214 creator A5052454334 @default.
• W2100063214 creator A5052833626 @default.
• W2100063214 creator A5070296304 @default.
• W2100063214 date "2006-07-01" @default.
• W2100063214 modified "2023-10-16" @default.
• W2100063214 title "Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia" @default.
• W2100063214 cites W1495287184 @default.
• W2100063214 cites W1982533441 @default.
• W2100063214 cites W1983186128 @default.
• W2100063214 cites W1983823691 @default.
• W2100063214 cites W1992338344 @default.
• W2100063214 cites W1993969382 @default.
• W2100063214 cites W2003774981 @default.
• W2100063214 cites W2030025004 @default.
• W2100063214 cites W2047959405 @default.
• W2100063214 cites W2051563676 @default.
• W2100063214 cites W2062849771 @default.
• W2100063214 cites W2063795565 @default.
• W2100063214 cites W2064373198 @default.
• W2100063214 cites W2092232971 @default.
• W2100063214 cites W2107572492 @default.
• W2100063214 cites W2123266930 @default.
• W2100063214 cites W2143180984 @default.
• W2100063214 cites W4246913131 @default.
• W2100063214 cites W4251118184 @default.
• W2100063214 cites W4252889419 @default.
• W2100063214 cites W4382916220 @default.
• W2100063214 doi "https://doi.org/10.1016/j.ajog.2005.12.049" @default.
• W2100063214 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16813756" @default.
• W2100063214 hasPublicationYear "2006" @default.
• W2100063214 type Work @default.
• W2100063214 sameAs 2100063214 @default.
• W2100063214 citedByCount "120" @default.
• W2100063214 countsByYear W21000632142012 @default.
• W2100063214 countsByYear W21000632142013 @default.
• W2100063214 countsByYear W21000632142014 @default.
• W2100063214 countsByYear W21000632142015 @default.
• W2100063214 countsByYear W21000632142016 @default.
• W2100063214 countsByYear W21000632142017 @default.
• W2100063214 countsByYear W21000632142018 @default.
• W2100063214 countsByYear W21000632142019 @default.
• W2100063214 countsByYear W21000632142020 @default.
• W2100063214 countsByYear W21000632142021 @default.
• W2100063214 countsByYear W21000632142022 @default.
• W2100063214 countsByYear W21000632142023 @default.
• W2100063214 crossrefType "journal-article" @default.
• W2100063214 hasAuthorship W2100063214A5017513634 @default.
• W2100063214 hasAuthorship W2100063214A5046597133 @default.
• W2100063214 hasAuthorship W2100063214A5052454334 @default.
• W2100063214 hasAuthorship W2100063214A5052833626 @default.
• W2100063214 hasAuthorship W2100063214A5070296304 @default.
• W2100063214 hasConcept C101544691 @default.
• W2100063214 hasConcept C126322002 @default.
• W2100063214 hasConcept C134018914 @default.
• W2100063214 hasConcept C16685009 @default.
• W2100063214 hasConcept C167734588 @default.
• W2100063214 hasConcept C170493617 @default.
• W2100063214 hasConcept C172680121 @default.
• W2100063214 hasConcept C2776871010 @default.
• W2100063214 hasConcept C2776953305 @default.
• W2100063214 hasConcept C2777025900 @default.
• W2100063214 hasConcept C2777218350 @default.
• W2100063214 hasConcept C2779184299 @default.
• W2100063214 hasConcept C2779234561 @default.
• W2100063214 hasConcept C42362537 @default.
• W2100063214 hasConcept C54355233 @default.
• W2100063214 hasConcept C71924100 @default.
• W2100063214 hasConcept C86803240 @default.
• W2100063214 hasConceptScore W2100063214C101544691 @default.
• W2100063214 hasConceptScore W2100063214C126322002 @default.
• W2100063214 hasConceptScore W2100063214C134018914 @default.
• W2100063214 hasConceptScore W2100063214C16685009 @default.
• W2100063214 hasConceptScore W2100063214C167734588 @default.
• W2100063214 hasConceptScore W2100063214C170493617 @default.
• W2100063214 hasConceptScore W2100063214C172680121 @default.
• W2100063214 hasConceptScore W2100063214C2776871010 @default.
• W2100063214 hasConceptScore W2100063214C2776953305 @default.
• W2100063214 hasConceptScore W2100063214C2777025900 @default.
• W2100063214 hasConceptScore W2100063214C2777218350 @default.
• W2100063214 hasConceptScore W2100063214C2779184299 @default.
• W2100063214 hasConceptScore W2100063214C2779234561 @default.
• W2100063214 hasConceptScore W2100063214C42362537 @default.
• W2100063214 hasConceptScore W2100063214C54355233 @default.
• W2100063214 hasConceptScore W2100063214C71924100 @default.
• W2100063214 hasConceptScore W2100063214C86803240 @default.
• W2100063214 hasIssue "1" @default.
• W2100063214 hasLocation W21000632141 @default.
• W2100063214 hasLocation W21000632142 @default.
• W2100063214 hasOpenAccess W2100063214 @default.
• W2100063214 hasPrimaryLocation W21000632141 @default.
• W2100063214 hasRelatedWork W1877802956 @default.
• W2100063214 hasRelatedWork W1963906907 @default.
• W2100063214 hasRelatedWork W2102881826 @default.
• W2100063214 hasRelatedWork W2353795412 @default.

• next